Immunocore Holdings plc (IMCR) Net Income by Year
Immunocore Holdings plc reported a net loss of $35.5M in fiscal year 2025. This represents an increase of 30.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $18.1M net loss. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Immunocore Holdings plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IMCR Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
IMCR Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Immunocore Holdings plc financials
Frequently Asked Questions
What was Immunocore Holdings plc's net income in fiscal year 2025?
Immunocore Holdings plc reported a net loss of $35.5M in fiscal year 2025.
How fast is Immunocore Holdings plc's net income growing?
Immunocore Holdings plc (IMCR) net income rose by 30.5% year over year, from -$51.1M to -$35.5M in fiscal year 2025.
What is Immunocore Holdings plc's net income over the last twelve months?
Immunocore Holdings plc (IMCR) reported a $18.1M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Immunocore Holdings plc's net income changed over the years?
Across the 5 fiscal years this page covers, Immunocore Holdings plc (IMCR) net income went from -$180.0M in fiscal year 2021 to -$35.5M in fiscal year 2025.
What was Immunocore Holdings plc's net income in the most recent quarter?
Immunocore Holdings plc (IMCR) reported -$808K in net income in Q2 2026. This represents an increase of 92.2% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Immunocore Holdings plc (IMCR) reported on that line in every period on record.